Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Abatacept in Juvenile Dermatomyositis
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
† Study has passed its completion date and status has not been verified in more than two years.